RECOMBINANT HUMAN PAPILLOMAVIRUS (HPV) QUADRIVALENT VACCINE

In June 2006, the quadrivalent HPV vaccine types 6,11,16,18 (GARDASILTM, manufactured by Merck and Co., Inc., Whitehouse Station, New Jersey) was licensed for use among females aged 9-26 years.

It aims to prevent HPV-type–related cervical cancer, cervical cancer precursors, vaginal and vulvar cancer precursors, and anogenital warts. Efficacy studies are on-going in men.

This vaccine is not recommended for use during pregnancy. Consult your health care professional for more details.

Minor symptoms may occur. If any of symptoms persist or worsen, tell your health care professional promptly.

Precautions

This product may contain inactive ingredients, which can cause allergic reactions or other problems.

 

Interactions

Drug interactions may change how your medications work or increase your risk for serious side effects. This document does not contain all possible drug interactions. Keep a list of all the products you use (including prescription/nonprescription drugs and herbal products) and share it with your health care professional. Do not starts, stop, or change the dosage of any medicines without your doctor’s approval.

Available brand:

  • Gardasil

Related Articles

VAMCEE

Sodium ascorbate is a mineral salt of ascorbic acid, commonly known as vitamin C. It's used as a dietary supplement [...]

UNASYN ORAL

Unasyn Oral is typically known as an intravenous medication. It is the combination antibiotic drug containing ampicillin and sulbactam. It's [...]

TAREG

Tareg (valsartan) is primarily prescribed for the treatment of hypertension (high blood pressure) and heart failure. It may be used [...]